Skip to main content
Charles Landen, MD, Obstetrics & Gynecology, Charlottesville, VA

Charles N. Landen MD MS

Gynecologic Oncology


Associate Professor, Obstetrics & Gynecology, University of Virginia

Join to View Full Profile
  • 1240 Lee StCharlottesville, VA 22908

  • Phone+1 434-924-5100

  • Fax+1 434-982-1840

Dr. Landen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Medical University of South Carolina
    Medical University of South CarolinaResidency, Obstetrics and Gynecology, 1998 - 2002
  • University of North Carolina at Chapel Hill School of Medicine
    University of North Carolina at Chapel Hill School of MedicineClass of 1998
  • University of Texas M D Anderson Cancer Center
    University of Texas M D Anderson Cancer CenterFellowship, Gynecologic Oncology

Certifications & Licensure

  • VA State Medical License
    VA State Medical License 2014 - 2026
  • AL State Medical License
    AL State Medical License 2009 - 2014
  • TX State Medical License
    TX State Medical License 2005 - 2010
  • SC State Medical License
    SC State Medical License 2000 - 2003
  • Obstetrics & Gynecology
    American Board of Obstetrics and Gynecology Obstetrics & Gynecology
  • Gynecologic Oncology
    American Board of Obstetrics and Gynecology Gynecologic Oncology

Publications & Presentations

PubMed

Press Mentions

  • Influx of FDA-Approved Novel Therapies Changing Gynecologic Oncology Care
    Influx of FDA-Approved Novel Therapies Changing Gynecologic Oncology CareMarch 24th, 2025
  • Phase 3 Trial of Pembrolizumab Combo in Advanced Ovarian Cancer Raises Questions
    Phase 3 Trial of Pembrolizumab Combo in Advanced Ovarian Cancer Raises QuestionsMarch 18th, 2025

Grant Support

  • Targeting RNA Polymerase I Transcription Machinery in Chemoresistant Ovarian CancerUNIVERSITY OF VIRGINIA2020–2025

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: